MedStar Montgomery Medical Center works closely with the MedStar Georgetown University Hospital cancer team to provide you with the best cancer treatment plan. Putting research to the test through this new partnership, our patients have access to cutting-edge technology and novel therapeutics that hold promise for the advancement of medicine and patient care. We provide seamless, coordinated care for our patients who choose to participate in one or more studies. Learn more about clinical trials available through the Lombardi Comprehensive Cancer Center.
The National Cancer Institute designates Lombardi a comprehensive cancer center, one of just 47 nationwide, and representing just 2 percent of cancer centers.
The criteria are rigorous, focused on a center’s ability to conduct meaningful research and incorporate promising results National Cancer Institute into clinical care. The designation means:
Some of our clinical trials attract patients from around the country. Our researchers are solving the mysteries of cancer’s origins and progression, to improve detection and prevention efforts. They’re also refining current therapies and creating better ones.